New ALS drug slips through telling Phase II clinical trials

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial -- an early, small-scale test to show if the drug works and continues to be safe.

Read the whole article on Science Daily

More from Science Daily